Related Experiment Video
Updated: Jun 23, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Diabetes: treating hypertension
1University of Michigan, Ann Arbor, MI, USA.
Insights
This systematic review examines antihypertensive treatments and blood pressure targets for people with diabetes. It synthesizes evidence on the effectiveness and safety of various medications and target ranges for managing hypertension in this population.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Hypertension is prevalent in people with diabetes, affecting 40% of those 45+ and over 60% of those 75+.
- Major cardiac events affect approximately 5% of people with diabetes and untreated hypertension annually, with higher risk in those with diabetic nephropathy.
Purpose of the Study:
- To evaluate the effects of antihypertensive medications and different blood pressure targets in individuals with diabetes.
- To provide evidence-based information on managing hypertension in the diabetic population.
Main Methods:
- A systematic review was conducted, searching major databases like Medline, Embase, and The Cochrane Library up to February 2007.
- Included studies comprised 22 systematic reviews, randomized controlled trials (RCTs), and observational studies.
- Searches also incorporated harms alerts from regulatory agencies like the FDA and MHRA.
Main Results:
- The review identified 22 relevant systematic reviews, RCTs, and observational studies.
- Evidence was gathered on the effectiveness and safety of various antihypertensive interventions.
Conclusions:
- The review presents information on the effectiveness and safety of alpha-blockers, angiotensin II receptor antagonists, angiotensin-converting enzyme inhibitors, beta-blockers, calcium channel blockers, and diuretics.
- It also discusses the impact of different blood pressure targets (lower or higher) in people with diabetes.
Introduction:
Among people with diabetes, around 40% of those aged 45 years, and more than 60% of those aged 75 years and over, will have a blood pressure greater than 140/90 mm Hg. Major cardiac events occur in approximately 5% of people with diabetes and untreated hypertension each year, and the risk is higher in those with other risk factors such as diabetic nephropathy.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antihypertensives, and of different blood pressure targets, in people with diabetes? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found 22 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: alpha-blockers, angiotensin II receptor antagonists, angiotensin-converting enzyme inhibitors, beta-blockers, blood pressure targets (lower or higher), calcium channel blockers, and diuretics.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology